108 related articles for article (PubMed ID: 1679908)
1. A computer simulation of the natural history of HIV infection: insights and implications.
Allen AD
Med Hypotheses; 1991 Jun; 35(2):122-5. PubMed ID: 1679908
[TBL] [Abstract][Full Text] [Related]
2. Studies of prognostic markers in HIV infection: implications for pathogenesis.
Phillips AN
AIDS; 1992 Nov; 6(11):1391-4. PubMed ID: 1361749
[No Abstract] [Full Text] [Related]
3. Progression of HIV-infection: markers or determinants.
Phair JP; Farzadegan H; Chmiel J; Muñoz A; Detels R; Saah A; Kaslow R
Trans Am Clin Climatol Assoc; 1993; 104():123-8; discussion 128-9. PubMed ID: 1364186
[No Abstract] [Full Text] [Related]
4. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
5. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals.
Taylor JM; Tan SJ; Detels R; Giorgi JV
AIDS; 1991 Feb; 5(2):159-67. PubMed ID: 1674418
[TBL] [Abstract][Full Text] [Related]
6. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIV-positive individuals.
Chevret S; Roquin H; Ganne P; Lefrère JJ
AIDS; 1992 Nov; 6(11):1349-52. PubMed ID: 1361748
[TBL] [Abstract][Full Text] [Related]
8. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
[TBL] [Abstract][Full Text] [Related]
9. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
[TBL] [Abstract][Full Text] [Related]
10. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL
AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
[TBL] [Abstract][Full Text] [Related]
12. The natural history of HIV infection: implications for the assessment of antiretroviral therapy.
Corey L; Coombs RW
Clin Infect Dis; 1993 Feb; 16 Suppl 1():S2-6. PubMed ID: 8093843
[TBL] [Abstract][Full Text] [Related]
13. Normalization of cytomegalovirus-specific CD4 T cells in HIV-1-infected individuals receiving antiretroviral therapy.
Grosse V; Schulte A; Weber K; Mendila M; Jacobs R; Schmidt RE; Heiken H
AIDS; 2002 May; 16(7):1075-7. PubMed ID: 11953477
[No Abstract] [Full Text] [Related]
14. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
[TBL] [Abstract][Full Text] [Related]
15. Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine.
Disla E; Rhim HR; Reddy A; Taranta A
J Rheumatol; 1994 Apr; 21(4):662-4. PubMed ID: 7913502
[TBL] [Abstract][Full Text] [Related]
16. On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection.
Machado SG; Gail MH; Ellenberg SS
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1065-73. PubMed ID: 1976795
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological assessment of HIV infection.
Bird AG
J Clin Pathol; 1992 Oct; 45(10):850-4. PubMed ID: 1358921
[No Abstract] [Full Text] [Related]
18. Distinct alterations in the distribution of CD45RO+ T-cell subsets in HIV-2 compared with HIV-1 infection.
Jaleco AC; Covas MJ; Pinto LA; Victorino RM
AIDS; 1994 Dec; 8(12):1663-8. PubMed ID: 7888114
[TBL] [Abstract][Full Text] [Related]
19. [Validity of an ELISA test for CD4+ T lymphocyte count and validity of total lymphocyte count in the assessment of immunodeficiency status in HIV infection].
Loua A; Kestens L; Vanham G; Boel L; Colebunders R; Gigase P
Ann Soc Belg Med Trop; 1994 Mar; 74(1):61-8. PubMed ID: 7912921
[TBL] [Abstract][Full Text] [Related]
20. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
